vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Avidia Bancorp, Inc. is the larger business by last-quarter revenue ($26.8M vs $20.6M, roughly 1.3× Entrada Therapeutics, Inc.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -84.4%, a 107.3% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-39.7M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
AVBC vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $20.6M |
| Net Profit | $5.3M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 33.3% | -106.0% |
| Net Margin | 22.9% | -84.4% |
| Revenue YoY | — | -65.2% |
| Net Profit YoY | — | -173.8% |
| EPS (diluted) | — | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $25.9M | — | ||
| Q1 25 | $22.9M | $20.6M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $94.7M | ||
| Q1 24 | — | $59.1M |
| Q4 25 | $5.3M | — | ||
| Q3 25 | $-907.0K | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $-11.6M | $-17.3M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $23.5M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | -7.0% | — | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | -72.0% | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | — | 56.4% | ||
| Q1 24 | — | 35.7% |
| Q4 25 | 22.9% | — | ||
| Q3 25 | -3.2% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | -50.5% | -84.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -71.7% | ||
| Q2 24 | — | 58.1% | ||
| Q1 24 | — | 39.7% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $417.3M |
| Total Assets | $2.8B | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | — | ||
| Q3 25 | $208.3M | — | ||
| Q2 25 | $592.5M | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $379.0M | — | ||
| Q3 25 | $372.0M | — | ||
| Q2 25 | $191.4M | — | ||
| Q1 25 | $186.1M | $417.3M | ||
| Q4 24 | — | $428.7M | ||
| Q3 24 | — | $422.4M | ||
| Q2 24 | — | $429.9M | ||
| Q1 24 | — | $269.4M |
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $2.7B | $486.5M | ||
| Q4 24 | — | $526.3M | ||
| Q3 24 | — | $554.6M | ||
| Q2 24 | — | $582.0M | ||
| Q1 24 | — | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $-38.5M |
| Free Cash FlowOCF − Capex | $24.1M | $-39.7M |
| FCF MarginFCF / Revenue | 89.9% | -192.9% |
| Capex IntensityCapex / Revenue | 16.0% | 5.6% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | — | ||
| Q3 25 | $24.1M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-2.2M | $-38.5M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | — | $-24.3M | ||
| Q2 24 | — | $39.8M | ||
| Q1 24 | — | $-25.5M |
| Q4 25 | $24.1M | — | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $-3.3M | — | ||
| Q1 25 | $-3.9M | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | 89.9% | — | ||
| Q3 25 | 83.2% | — | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | -16.9% | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 7.2% | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
